Georg Casari, who co-founded Lion Bioscience in 1997 and before that worked in high-throughput sequencing at EMBL and the EBI, became vice president of informatics at Cellzome in Heidelberg.
Taylor Crouch resigned from his position as president and CEO of pharmacogenomics firm Variagenics. Joseph Mohr, former VP of marketing and business development, was appointed president and CBO, while CFO Richard Shea took on the role of COO.
Biochip company Zyomyx appointed Hirdey Bhathal as vice president of corporate development. Bhathal was previously at Agilent Technologies and Li-Cor Biotechnology.
Paul Davie joins InforSense, a discovery informatics firm in London, as president and chief operating officer. Davie comes from Accelrys, where he was a general manager and senior director.
Raju Kucherlapati, steps in as scientific director of the new Harvard-Partners Center for Genetic and Genomic Research.
Morphochem hired Brian Bullard as its new informatics veep. Bullard has spent 18 years in the industry and was last VP and CIO at AxCell Biosciences.
Redwood City, Calif.’s Deltagen announced that Michael Sember, last seen as business development VP at Elan, comes aboard as president and COO. Meanwhile, CEO William Matthews became chairman of the board.
Gordon Wong moves from one startup to another, trading in US Genomics for a post at EngeneOS in Waltham, Mass., where he’s the new chief scientific officer.
Nat Goodman, GT’s IT Guy columnist and former senior veep at 3rd Millennium, has been named senior research scientist at Lee Hood’s Institute for Systems Biology in Seattle. He’ll also be paddling over to Alaska on occasion for a new appointment as affiliate bioinformatics professor.
Props to the genome crowd for sweeping the Gairdner International Awards, begun by the Gairdner Foundation of Toronto to recognize advancements in medical research. The recipients of the award, and $30,000 apiece, were: Eric Lander at Whitehead; Phillip Green and Maynard Olson, both of the University of Washington; Sanger’s John Sulston; erstwhile Celera chief Craig Venter; Michael Waterman at University of Southern California; Bob Waterston at Washington University; and Jean Weissenbach of Genoscope in Paris.
David Deems from Union Biometrica joins applied genomics company Exact Sciences as vice president of product development.